 SOLANA BEACH, CA ACCESSWIRE May 13, 2022 Artelo Biosciences, Inc. Artelo or the Company NASDAQ:ARTL, a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today announced that Gregory D. Gorgas, Chief Executive Officer of Artelo has been invited to present at the Spring Into Action - Best Ideas Virtual Investor Conference, which is being held virtually May 16th - 20th, 2022. 